Top

Reactions Weekly

Published in:

01-11-2021 | Budesonide | Case report

Ciclosporin/letermovir/mycophenolate-mofetil

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Serio B, et al. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study. Infezioni in Medicina 29: 102-113, No. 1, Mar 2021

Title: Ciclosporin/letermovir/mycophenolate-mofetil
Lack of efficacy: case report
Publication date: 01-11-2021
Publisher: Springer International Publishing
Keywords: Budesonide
Ciclosporine
Graft-Versus-Host Disease
Graft-Versus-Host Disease
Mycophenolate Mofetil
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-06065-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ciclosporin/letermovir/mycophenolate-mofetil

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Multiple drugs

Multiple drugs

Olmesartan-medoxomil

Methylprednisolone

Valaciclovir

Dexamethasone/immune globulin/romiplostim